EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process

Ju-Hyun Yoon iD, Chae-Won Jeon, Young-Joon Park iD, Joo-Eun Kim iD

Pharmaceutics · 07.07.2026 · 18 (7) · 833

DOI: 10.3390/pharmaceutics18070833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 07.07.2026. Verfasst von Ju-Hyun Yoon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amiodarone hydrochloride is an antiarrhythmic agent, primarily classified as a Vaughan Williams Class III antiarrhythmic agent, used for the treatment and prevention of arrhythmia and designated as an essential national drug. Recently, the need to develop formulations suitable for continuous manufacturing, which is gaining significant attention in the pharmaceutical industry, has emerged.

Objective

The objective of this study was to evaluate the formulation potential of amiodarone hydrochloride for the development of an oral tablet, with a specific focus on improving the initial dissolution rate to design a formulation optimized for continuous manufacturing.

Methods

The primary physicochemical properties of amiodarone hydrochloride were predicted and subsequently validated through experimental characterization. Furthermore, the ratios of the binder and granulation liquid were optimized to facilitate robust and successful production via continuous manufacturing.

Results

A new amiodarone hydrochloride tablet formulation, optimized for a continuous wet granulation process, was successfully developed by improving the initial dissolution rate through the optimization of the respective amounts of binder and granulation liquid.

Conclusions

The optimal formulation design established in this research provides a critical foundation for enhancing the applicability of a continuous process in the manufacturing of amiodarone hydrochloride tablets.

Schlagwörter

Stichwörter der Autor:innen

amiodarone hydrochloridecontinuous manufacturingformulationoptimizationpreformulation

Autor:innen und Institutionen

  • Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
  • College of Pharmacy, Ajou University, 206 World Cup-Ro, Yeongtong-Gu, Suwon 16499, Republic of Korea.
  • Department of Biopharmaceutical Chemistry, School of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
  • Department of Pharmaceutical Engineering, Kookmin University, Seoul 02707, Republic of Korea.

ORCID-Profile: Ju-Hyun Yoon, Young-Joon Park, Joo-Eun Kim

Förderung

  • Ministry of Trade, Industry and Energy

Zitieren

APA

Yoon, J. H., Jeon, C. W., Park, Y. J., & Kim, J. E. (2026). Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process. Pharmaceutics, 18(7), 833. https://doi.org/10.3390/pharmaceutics18070833

Vancouver

Yoon JH, Jeon CW, Park YJ, Kim JE. Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process. Pharmaceutics. 2026;18(7):833. doi:10.3390/pharmaceutics18070833

BibTeX
@article{Yoon2026,
  author = {Yoon, Ju-Hyun and Jeon, Chae-Won and Park, Young-Joon and Kim, Joo-Eun},
  title = {Formulation Design of Amiodarone Hydrochloride Tablets Optimized for a Continuous Manufacturing Process},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {833},
  doi = {10.3390/pharmaceutics18070833}
}
Kostenlos starten →